As of 2026-09-27, the Relative Valuation of Revance Therapeutics Inc (RVNC) is (36.13) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.65 USD, the upside of Revance Therapeutics Inc based on Relative Valuation is -1089.9%.
The range of the Relative Valuation is (24.31) - (38.98) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.9x - 33.7x | 22.5x |
| Forward P/E multiples | 13.8x - 22.1x | 18.4x |
| Fair Price | (24.31) - (38.98) | (36.13) |
| Upside | -766.1% - -1167.8% | -1089.9% |
| Date | P/E |